Moleculin Biotech (MBRX) Tops Q2 EPS by 7c
Moleculin Biotech (NASDAQ: MBRX) reported Q2 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
Moleculin Biotech (NASDAQ: MBRX) reported Q2 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.